Amplitude Venture Capital — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
Fluid Biomed develops a bioresorbable polymer-based stent designed to treat brain aneurysms by diverting blood flow and reducing risk of stroke.
BiotechDeep TechHealthtechMedical DevicesCalgary, CA
Dr. John H. Wong(Co-founder & Chief Executive Officer)Dr. Alim P. Mitha(Co-founder, President & Chief Technology Officer)
Co-investorsAccelerate FundLifeArc VenturesShangBay Capital LLCThin Air LabsUCeed FundsIAG Capital Partners
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Ability biologics
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.